Invited commentary. Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO).
Kashyap
Vikram S
VS
D000208:Acute Disease; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D002406:Catheterization, Peripheral; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006083:Graft Occlusion, Vascular / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007511:Ischemia / Q000188:drug therapy / Q000209:etiology; D008666:Metalloendopeptidases / Q000008:administration & dosage* / Q000009:adverse effects; D020551:Pulse Therapy, Drug; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D015912:Thrombolytic Therapy / Q000009:adverse effects; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures
D005343:Fibrinolytic Agents; D008666:Metalloendopeptidases; C436755:alfimeprase